| Literature DB >> 35281838 |
David Kenny1,2, Tara R Carthy3, Craig P Murphy2, Roy D Sleator2, Ross D Evans4, Donagh P Berry1.
Abstract
The objective of the present study was to quantify the association between both pedigree and genome-based measures of global heterozygosity and carcass traits, and to identify single nucleotide polymorphisms (SNPs) exhibiting non-additive associations with these traits. The carcass traits of interest were carcass weight (CW), carcass conformation (CC) and carcass fat (CF). To define the genome-based measures of heterozygosity, and to quantify the non-additive associations between SNPs and the carcass traits, imputed, high-density genotype data, comprising of 619,158 SNPs, from 27,213 cattle were used. The correlations between the pedigree-based heterosis coefficient and the three defined genomic measures of heterozygosity ranged from 0.18 to 0.76. The associations between the different measures of heterozygosity and the carcass traits were biologically small, with positive associations for CW and CC, and negative associations for CF. Furthermore, even after accounting for the pedigree-based heterosis coefficient of an animal, part of the remaining variability in some of the carcass traits could be captured by a genomic heterozygosity measure. This signifies that the inclusion of both a heterosis coefficient based on pedigree information and a genome-based measure of heterozygosity could be beneficial to limiting bias in predicting additive genetic merit. Finally, one SNP located on Bos taurus (BTA) chromosome number 5 demonstrated a non-additive association with CW. Furthermore, 182 SNPs (180 SNPs on BTA 2 and two SNPs on BTA 21) demonstrated a non-additive association with CC, while 231 SNPs located on BTA 2, 5, 11, 13, 14, 18, 19 and 21 demonstrated a non-additive association with CF. Results demonstrate that heterozygosity both at a global level and at the level of individual loci contribute little to the variability in carcass merit.Entities:
Keywords: association analysis; carcass traits; dominance; genomic heterozygosity; heterosis; non-additive
Year: 2022 PMID: 35281838 PMCID: PMC8908906 DOI: 10.3389/fgene.2022.789270
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Spearman correlation coefficients between the pedigree-based heterosis coefficient and the three genomic heterozygosity measures, namely observed heterozygosity, homozygosity by locus and runs of heterozygosity.
| Observed heterozygosity | Homozygosity by locus | Runs of heterozygosity | |
|---|---|---|---|
| Heterosis coefficient | 0.76 | 0.76 | 0.18 |
| Observed heterozygosity | — | 0.98 | 0.30 |
| Homozygosity by locus | — | — | 0.28 |
Regression coefficients (standard error in parenthesis) from the regression of carcass weight, carcass conformation and carcass fat on the heterosis coefficient (Het) or one of the genomic heterozygosity measures, namely observed heterozygosity (OH), homozygosity by locus (HL) and runs of heterozygosity (ROHet), and a combination of the heterosis coefficient and one, or more, of the genomic heterozygosity measures simultaneously included in the statistical model.
| Heterosis/Heterozygosity measure(s) included in the model | Het | OH | HL | ROHet |
|---|---|---|---|---|
| Carcass weight (kg) | — | — | — | — |
| Separate inclusion of each measure | 2.78 (0.71) | 1.05 (0.16) | 1.13 (0.15) | 0.003 (0.03) |
| Het and OH | 0.51 (0.82) | 0.99 (0.18) | — | — |
| Het and HL | −0.01 (0.83) | — | 1.13 (0.17) | — |
| Het and ROHet | 2.80 (0.71) | — | — | −0.01 (0.03) |
| Het, OH and ROHet | 0.47 (0.83) | 1.05 (0.19) | — | −0.05 (0.03) |
| Het, HL and ROHet | −0.05 (0.83) | — | 1.19 (0.18) | −0.06 (0.03) |
| Carcass conformation [scored 1 (poor) to15 (excellent)] | — | — | — | — |
| Separate inclusion of each measure | −0.20 (0.03) | −0.05 (0.01) | −0.03 (0.01) | −0.005 (0.001) |
| Het and OH | −0.13 (0.03) | 0.03 (0.001) | — | — |
| Het and HL | −0.16 (0.03) | — | -0.02 (0.006) | — |
| Het and ROHet | −0.20 (0.03) | — | — | 0.004 (0.001) |
| Het, OH and ROHet | −0.13 (0.03) | -0.03 (0.01) | — | 0.003 (0.001) |
| Het, HL and ROHet | −0.17 (0.03) | — | -0.01 (0.01) | 0.004 (0.001) |
| Carcass fat [scored 1 (thin) to 15 (fat)] | — | — | — | — |
| Separate inclusion of each measure | 0.62 (0.04) | 0.19 (0.01) | 0.17 (0.01) | 0.013 (0.001) |
| Het and OH | 0.24 (0.05) | 0.16 (0.01) | — | — |
| Het and HL | 0.28 (0.05) | — | 0.14 (0.01) | — |
| Het and ROHet | 0.60 (0.04) | — | — | 0.01 (0.002) |
| Het, OH and ROHet | 0.24 (0.05) | 0.16 (0.01) | — | 0.003 (0.002) |
| Het, HL and ROHet | 0.29 (0.05) | — | 0.13 (0.01) | 0.004 (0.002) |
Represents an increase of 1 in the heterosis coefficient.
Represents an increase of 0.01 in observed heterozygosity or homozygosity by locus.
Represents an increase of 1 in runs of heterozygosity.
Represent a significant association between the carcass trait and the measure in question (p ≤ 0.05).
FIGURE 1Manhattan plots showing–log10 (q-values) of the association between the additive [(A) graph] and dominance [(B) graph] effect of each single nucleotide polymorphism (SNP) from each Bos taurus (BTA) chromosome and the adjusted carcass weights. The red lines represent the threshold for significant (q values ≤0.01) SNPs.
Details of quantitative trait loci (QTL) regions comprising single nucleotide polymorphisms (SNPs) with significant additive associations with carcass weight, namely chromosome number (BTA), start and end position, number of significant SNPs, and details of the most significant SNP of each, namely name, position, effect and frequency (Freq) of the major allele, p-value representing the significance difference of the effect from zero, name of nearest gene, SNP annotation, and other genes within 500 Kb of the lead SNP.
| BTA | QTL | Most strongly associated SNP in QTL | Other genes in region | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Start | End | SNPs | SNP name | Position | Effect | Freq |
| Gene | Annotation | ||
| 2 | 2,152,312 | 2,214,590 | 2 | rs134902036 | 2,214,590 | -1.84 | 0.72 | 4.09 × 10–12 | PLEKHB2 | Downstream | ARHGEF4, FAM168B |
| 2 | 2,329,987 | 2,333,917 | 3 | rs109052645 | 2,329,987 | -0.826 | 0.64 | 4.88 × 10–7 | PLEKHB2 | Downstream | ARHGEF4, FAM168B |
| 2 | 3,502,283 | 3,524,560 | 7 | rs109607574 | 3,510,323 | 1.132 | 0.67 | 1.34 × 10–10 | — | Intergenic | — |
| 2 | 4,099,666 | 4,101,545 | 3 | rs135686370 | 4,100,735 | 1.132 | 0.85 | 3.16 × 10–10 | HS6ST1 | Upstream | UGGT1, SAP130 |
| 6 | 39,221,671 | 39,769,206 | 16 | rs137720687 | 39,425,007 | 1.276 | 0.88 | 3.29 × 10–15 | SLIT2 | Intron | — |
| 6 | 40,170,015 | 40,326,680 | 16 | rs135203216 | 40,238,070 | 1.215 | 0.95 | 3.58 × 10–13 | KCNIP4 | Intron | SLIT2, PACRGL |
| 14 | 26,969,707 | 26,971,048 | 2 | rs132861240 | 26,969,707 | 1.241 | 0.78 | 3.31 × 10–7 | ASPH | Downstream | CHD7, CLVS1 |
FIGURE 2Manhattan plots showing–log10 (q-values) of the association between the additive [(A) graph] and dominance [(B) graph] effect of each single nucleotide polymorphism (SNP) from each Bos taurus (BTA) chromosome and the adjusted carcass conformation scores. The red lines represent the threshold for significant (q values ≤0.01) SNPs.
Details of quantitative trait loci (QTL) regions comprising single nucleotide polymorphisms (SNPs) with significant additive associations with carcass conformation, namely chromosome number (BTA), start and end position, number of significant SNPs, and details of the most significant SNP of each, namely name, position, effect and frequency (Freq) of the major allele, p-value representing the significance difference of the effect from zero, name of nearest gene, SNP annotation, and other genes within 500 Kb of the lead SNP.
| BTA | QTL | Most strongly associated SNP in QTL | Other genes in region | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Start | End | SNPs | SNP name | Position | Effect | Freq |
| Gene | Annotation | ||
| 2 | 565,339 | 569,844 | 2 | rs109043505 | 565,339 | 0.047 | 0.81 | 1.60 × 10–14 | OCA2 | Intron | LGSN, HERC2, NIPA1, NIPA2 |
| 2 | 682,101 | 791,879 | 6 | rs109878315 | 729,681 | -0.035 | 0.87 | 8.95 × 10–9 | HERC2 | Intron | LGSN, OCA2, NIPA1, CYFIP1 |
| 2 | 1,248,113 | 1,283,778 | 5 | rs109730024 | 1,283,778 | 0.048 | 0.63 | 1.96 × 10–14 | TUBGCP5 | Intron | HERC2, NIPA1, NIPA2, CYFIP1, CCDC115, IMP4, PTPN18, AMER3, ARHGEF4 |
| 2 | 1,619,549 | 1,664,976 | 15 | rs133205474 | 1,622,661 | 0.047 | 0.85 | 6.16 × 10–14 | ARHGEF4 | Upstream | CYFIP1, TUBGCP5, CCDC115, IMP4, PTPN18, AMER3, FAM168B, PLEKHB2 |
| 2 | 1,846,469 | 1,848,495 | 3 | rs109673771 | 1,846,469 | 0.032 | 0.76 | 2.95 × 10–8 | ARHGEF4 | Intron | PTPN18, AMER3, FAM168B, PLEKHB2 |
| 2 | 2,152,312 | 2,214,590 | 2 | rs134902036 | 2,214,590 | -0.066 | 0.72 | 1.77 × 10–26 | PLEKHB2 | Downstream | ARHGEF4, FAM168B |
| 2 | 2,230,600 | 2,423,609 | 16 | rs110980261 | 2,361,337 | 0.058 | 0.73 | 3.01 × 10–23 | PLEKHB2 | Downstream | ARHGEF4,FAM168B |
| 2 | 2,921,455 | 2,924,516 | 2 | rs136598546 | 2,924,516 | 0.042 | 0.64 | 2.31 × 10–9 | — | Intergenic | — |
| 2 | 2,994,646 | 3,014,162 | 2 | rs135773145 | 3,014,162 | -0.085 | 0.67 | 3.41 × 10–42 | — | Intergenic | — |
| 2 | 3,227,403 | 3,301,918 | 13 | rs110614558 | 3,236,835 | 0.081 | 0.55 | 3.45 × 10–33 | — | Intergenic | — |
| 2 | 3,433,179 | 3,713,255 | 15 | rs133762933 | 3,713,255 | 0.081 | 0.54 | 8.59 × 10–34 | HS6ST1 | Upstream | — |
| 2 | 3,904,008 | 3,971,148 | 15 | rs136098660 | 3,941,047 | 0.055 | 0.51 | 7.20 × 10–19 | HS6ST1 | Upstream | UGGT1 |
| 2 | 4,099,666 | 4,101,545 | 3 | rs135686370 | 4,100,735 | 0.078 | 0.85 | 1.50 × 10–27 | HS6ST1 | Upstream | UGGT1, SAP130 |
| 2 | 4,216,110 | 4,226,751 | 6 | rs110759081 | 4,216,110 | -0.071 | 0.89 | 1.45 × 10–32 | HS6ST1 | Intron | UGGT1, SAP130, AMMECR1L, POLR2D, WDR33 |
| 2 | 4,591,262 | 4,607,827 | 2 | rs42904822 | 4,591,262 | 0.053 | 0.81 | 4.37 × 10–9 | AMMECR1L | Upstream | HS6ST1,UGGT1, SAP130, POLR2D, WDR33, SFT2D3, LIMS2, GPR17, MYO7B, IWS1 |
| 2 | 4,860,070 | 4,861,022 | 2 | rs110482569 | 4,861,022 | 0.049 | 0.66 | 4.09 × 10–14 | LIMS2 | Intron | UGGT1, SAP130, AMMECR1L, POLR2D, WDR33, SFT2D3, GPR17, MYO7B, IWS1, PROC, MAP3K2, ERRC2, CYP27C1 |
| 2 | 5,109,012 | 5,128,788 | 4 | rs108948452 | 5,115,682 | -0.045 | 0.85 | 2.49 × 10–13 | PROC | Downstream | AMMECR1L, POLR2D, WDR33, SFT2D3, GPR17, MYO7B, IWS1, PROC, MAP3K2, ERRC2, CYP27C1, BIN1 |
| 2 | 5,374,531 | 5,480,052 | 8 | rs134297176 | 5,423,184 | 0.059 | 0.53 | 2.14 × 10–21 | BIN1 | Intron | MYO7B, IWS1, MAP3K2, ERCC3, CYP27C1, NAB1, NEMP2, MFSD6 |
| 2 | 5,931,228 | 5,937,091 | 4 | rs137651762 | 5,931,228 | 0.065 | 0.68 | 1.28 × 10–14 | INPP1 | Upstream | BIN1, NAB1, NEMP2, MFSD6, HIBCH, MSTN |
Details of quantitative trait loci (QTL) regions comprising single nucleotide polymorphisms (SNPs) with significant dominance associations with carcass conformation, namely chromosome number (BTA), start and end position, number of significant SNPs, and details of the most significant SNP of each, namely name, position, effect (Effect) and frequency (Freq) of the heterozygous genotype, p-value representing the significance of the difference of the effect from zero, name of nearest gene, annotation, and other genes within 0.5 Mb of the lead SNP.
| BTA | QTL | Most strongly associated SNP in QTL | Other genes in region | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Start | End | SNPs | SNP name | Position | Effect | Freq |
| Gene | Annotation | ||
| 2 | 1,248,113 | 1,283,778 | 3 | rs109730024 | 1,283,778 | −0.048 | 0.47 | 1.35 × 10–7 | TUBGCP5 | Intron | HERC2, NIPA1, NIPA2, CYFIP1, CCDC115, IMP4, PTPN18, AMER3, ARHGEF4 |
| 2 | 1,574,632 | 1,579,045 | 2 | rs134698928 | 1,579,045 | −0.061 | 0.10 | 1.59 × 10–12 | ARHGEF4 | Upstream | CYFIP1, TUBGCP5, CCDC115, IMP4, PTPN18, AMER3, FAM168B, PLEKHB2 |
| 2 | 1,619,549 | 1,647,935 | 10 | rs133205474 | 1,622,661 | −0.063 | 0.49 | 1.13 × 10–12 | ARHGEF4 | Upstream | CYFIP1, TUBGCP5, CCDC115, IMP4, PTPN18, AMER3, FAM168B, PLEKHB2 |
| 2 | 1,847,259 | 1,848,495 | 2 | rs109701201 | 1,848,495 | −0.041 | 0.36 | 2.34 × 10–6 | ARHGEF4 | Intron | PTPN18, AMER3, FAM168B, PLEKHB2 |
| 2 | 2,152,312 | 2,214,590 | 2 | rs134902036 | 2,214,590 | −0.067 | 0.16 | 3.77 × 10–14 | PLEKHB2 | Downstream | ARHGEF4, FAM168B |
| 2 | 2,230,600 | 2,434,950 | 21 | rs110980261 | 2,361,337 | −0.99 | 0.45 | 1.92 × 10–30 | PLEKHB2 | Downstream | ARHGEF4, FAM168B |
| 2 | 2,591,903 | 2,934,187 | 13 | rs133659602 | 2,780,706 | −0.065 | 0.44 | 3.48 × 10–14 | — | Intergenic | — |
| 2 | 3,212,823 | 3,264,352 | 9 | rs110614558 | 3,236,835 | −0.113 | 0.43 | 6.48 × 10–32 | — | Intergenic | — |
| 2 | 3,433,179 | 3,735,840 | 15 | rs109107915 | 3,502,283 | −0.105 | 0.49 | 2.08 × 10–29 | — | Intergenic | — |
| 2 | 3,752,032 | 3,754,081 | 2 | rs136576511 | 3,754,081 | −0.064 | 0.33 | 1.51 × 10–6 | HS6ST1 | Upstream | — |
| 2 | 3,904,008 | 3,914,796 | 3 | rs134035605 | 3,904,008 | −0.065 | 0.44 | 1.43 × 10–13 | HS6ST1 | Upstream | UGGT1 |
| 2 | 3,938,844 | 3,971,148 | 11 | rs136098660 | 3,941,047 | −0.083 | 0.43 | 8.99 × 10–20 | HS6ST1 | Upstream | UGGT1 |
| 2 | 3,987,043 | 3,988,311 | 2 | rs135950969 | 3,987,043 | −0.067 | 0.50 | 1.80 × 10–7 | HS6ST1 | Upstream | UGGT1, SAP130 |
| 2 | 4,021,245 | 4,101,545 | 5 | rs135686370 | 4,100,735 | −0.097 | 0.46 | 1.09 × 10–24 | HS6ST1 | Upstream | UGGT1, SAP130 |
| 2 | 4,186,409 | 4,189,376 | 2 | rs132939901 | 4,186,409 | −0.047 | 0.49 | 1.63 × 10–7 | HS6ST1 | Upstream | UGGT1, SAP130, AMMECR1L, POLR2D, WDR33 |
| 2 | 4,202,001 | 4,335,970 | 18 | rs136251990 | 4,212,079 | −0.096 | 0.38 | 9.13 × 10–20 | HS6ST1 | Intron | UGGT1, SAP130, AMMECR1L, POLR2D, WDR33 |
| 2 | 4,591,262 | 4,607,827 | 2 | rs42904822 | 4,591,262 | −0.068 | 0.20 | 8.14 × 10–9 | AMMECR1L | Upstream | HS6ST1, UGGT1, SAP130, AMMECR1L, POLR2D, WDR33, SFT2D3, LIMS2, GPR17, MYO7B, IWS1 |
| 2 | 5,328,432 | 5,358,183 | 7 | rs109091526 | 5,358,183 | −0.065 | 0.48 | 1.34 × 10–8 | CYP27C1 | Downstream | LIMS2, GPR17, MYO7B, IWS1, PROC, MAP3K2, ERCC3, BIN1, NAB1, NEMP2, MFSD6 |
| 2 | 5,370,442 | 5,423,184 | 4 | rs134297176 | 5,423,184 | −0.059 | 0.30 | 4.86 × 10–11 | BIN1 | Intron | MYO7B, IWS1, PROC, MAP3K2, ERCC3, BIN1, NAB1, NEMP2, MFSD6 |
| 2 | 5,931,228 | 5,937,091 | 4 | rs109266532 | 5,935,155 | 0.012 | 0.47 | 6.08 × 10–10 | INPP1 | Intron | BIN1, NAB1, NEMP2, MFSD6, HIBCH, MSTN, PMS1 |
| 2 | 6,005,043 | 6,008,468 | 2 | rs13544915 | 6,005,043 | −0.072 | 0.15 | 6.07 × 10–10 | HIBCH | Intron | NAB1, NEMP2, MFSD6, INPP1, MSTN, PMS1 |
FIGURE 3Manhattan plots showing–log10 (q-values) of the association between the additive [(A) graph] and dominance [(B) graph] effect of each single nucleotide polymorphism (SNP) from each Bos taurus (BTA) chromosome and the adjusted carcass fat scores. The red lines represent the threshold for significant (q values ≤0.01) SNPs.
Details of quantitative trait loci (QTL) regions comprising single nucleotide polymorphisms (SNPs) with significant additive associations with carcass fat, namely chromosome number (BTA), start and end position, number of significant SNPs, and details of the most significant SNP of each, namely name, position, effect and frequency (Freq) of the major allele, p-value representing the significance difference of the effect from zero, name of nearest gene, SNP annotation, and other genes within 0.5 Mb of the lead SNP.
| BTA | QTL | Most strongly associated SNP in QTL | Other genes in region | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Start | End | SNPs | SNP name | Position | Effect | Freq |
| Gene | Annotation | ||
| 2 | 1,248,113 | 1,283,778 | 5 | rs134533754 | 1,248,113 | −0.070 | 0.67 | 2.61 × 10–14 | TUBGCP5 | Intron | HERC2, NIPA1, NIPA2, CYFIP1, CCDC115, IMP4, PTPN18, AMER3, ARHGEF4 |
| 2 | 1,619,549 | 1,664,976 | 9 | rs133205474 | 1,622,661 | −0.064 | 0.85 | 8.20 × 10–12 | ARHGEF4 | Upstream | CYFIP1, TUBGCP5, CCDC115, IMP4, PTPN18, AMER3, FAM168B, PLEKHB2 |
| 2 | 2,152,312 | 2,214,590 | 2 | rs134902036 | 2,214,590 | 0.080 | 0.72 | 1.92 × 10–9 | PLEKHB2 | Downstream | ARHGEF4, FAM168B |
| 2 | 2,329,987 | 2,336,742 | 4 | rs110108312 | 2,333,917 | 0.049 | 0.65 | 8.52 × 10–8 | PLEKHB2 | Downstream | ARHGEF4, FAM168B |
| 2 | 2,361,337 | 2,401,930 | 2 | rs110957350 | 2,401,930 | 0.077 | 0.73 | 3.55 × 10–18 | PLEKHB2 | Downstream | FAM168B |
| 2 | 2,994,646 | 3,014,162 | 2 | rs135773145 | 3,014,162 | 0.091 | 0.67 | 7.04 × 10–22 | — | Intergenic | — |
| 2 | 3,227,403 | 3,264,352 | 5 | rs109033262 | 3,227,403 | -0.094 | 0.72 | 2.48 × 10–20 | — | Intergenic | — |
| 2 | 3,502,283 | 3,526,094 | 9 | rs109354447 | 3,514,143 | −0.087 | 0.79 | 5.07 × 10–19 | — | Intergenic | — |
| 2 | 3,909,497 | 3,914,796 | 2 | rs109822566 | 3,914,796 | −0.049 | 0.60 | 1.36 × 10–7 | HS6ST1 | Upstream | UGGT1 |
| 2 | 3,938,844 | 3,960,478 | 6 | rs136098660 | 3,941,047 | −0.057 | 0.51 | 1.77 × 10–9 | HS6ST1 | Upstream | UGGT1, SAP130 |
| 2 | 4,099,666 | 4,101,545 | 3 | rs132696854 | 4,101,545 | −0.076 | 0.85 | 2.38 × 10–14 | HS6ST1 | Upstream | UGGT1, SAP130, AMMECR1L |
| 2 | 4,216,110 | 4,217,841 | 2 | rs110759081 | 4,216,110 | 0.081 | 0.88 | 2.27 × 10–19 | HS6ST1 | Intron | UGGT1, SAP130, AMMECR1L, POLR2D, WDR33 |
| 2 | 4,752,309 | 4,784,432 | 2 | rs135023953 | 4,752,309 | 0.072 | 0.88 | 1.68 × 10–16 | WDR33 | Intron | UGGT1, SAP130, AMMECR1L, POLR2D,SFT2D3, LIMS2, GPR17, MYO7B, IWS1, PROC, MAP3K2, ERCC3 |
| 2 | 5,374,531 | 5,480,052 | 5 | rs134297176 | 5,423,184 | -0.059 | 0.53 | 2.77 × 10–10 | BIN1 | Intron | MYO7B, IWS1, PROC, MAP3K2, ERCC3, CYP27C1, NAB1, NEMP2, MFSD6 |
Details of quantitative trait loci (QTL) regions comprising single nucleotide polymorphisms (SNPs) with significant dominance associations with carcass fat, namely chromosome number (BTA), start and end position, number of significant SNPs, and details of the most significant SNP of each, namely name, position, effect (Effect) and frequency (Freq) of the heterozygous genotype, p-value representing the significance of the difference of the effect from zero, name of nearest gene, annotation, and other genes within 0.5 Mb of the lead SNP.
| BTA | QTL | Most strongly associated SNP in QTL | Other genes in region | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Start | End | SNPs | SNP name | Position | Effect | Freq |
| Gene | Annotation | ||
| 2 | 1,248,113 | 1,290,025 | 5 | rs109730024 | 1,283,778 | 0.094 | 0.46 | 8.27 × 10–8 | TUBGCP5 | Intron | HERC2, NIPA1, NIPA2, CYFIP1, CCDC115, IMP4, PTPN18, AMER3, ARHGEF4 |
| 2 | 1,574,632 | 1,579,045 | 2 | rs134698928 | 1,579,045 | 0.106 | 0.49 | 4.37 × 10–15 | ARHGEF4 | Upstream | CYFIP1, TUBGCP5, CCDC115, IMP4, PTPN18, AMER3, FAM168B, PLEKHB2 |
| 2 | 1,619,549 | 1,664,976 | 17 | rs43284356 | 1,643,777 | 0.101 | 0.46 | 1.04 × 10–12 | ARHGEF4 | Upstream | CYFIP1, TUBGCP5, CCDC115, IMP4, PTPN18, AMER3, FAM168B, PLEKHB2 |
| 2 | 2,152,312 | 2,214,590 | 2 | rs134902036 | 2,214,590 | 0.095 | 0.40 | 2.99 × 10–12 | PLEKHB2 | Downstream | ARHGEF4, FAM168B |
| 2 | 2,230,600 | 2,401,930 | 20 | rs110957350 | 2,401,930 | 0.140 | 0.40 | 7.84 × 10–33 | PLEKHB2 | Downstream | FAM168B |
| 2 | 2,591,903 | 2,936,048 | 13 | rs137575666 | 2,933,071 | 0.117 | 0.49 | 3.78 × 10–11 | — | Intergenic | — |
| 2 | 3,205,071 | 3,301,918 | 15 | rs108984792 | 3,228,751 | 0.142 | 0.43 | 8.35 × 10–24 | — | Intergenic | — |
| 2 | 3,433,179 | 3,526,094 | 11 | rs109354447 | 3,514,143 | 0.151 | 0.33 | 6.14 × 10–27 | — | Intergenic | — |
| 2 | 3,904,008 | 3,914,796 | 3 | rs109822566 | 3,914,796 | 0.115 | 0.45 | 2.51 × 10–17 | HS6ST1 | Upstream | UGGT1 |
| 2 | 3,938,844 | 3,971,148 | 9 | rs136098660 | 3,941,047 | 0.130 | 0.50 | 2.39 × 10–21 | HS6ST1 | Upstream | UGGT1 |
| 2 | 4,099,666 | 4,101,545 | 3 | rs135686370 | 4,100,735 | 0.099 | 0.25 | 5.43 × 10–12 | HS6ST1 | Upstream | UGGT1, SAP130 |
| 2 | 4,210,568 | 4,363,340 | 11 | rs110759081 | 4,216,110 | 0.088 | 0.20 | 1.74 × 10–11 | HS6ST1 | Intron | UGGT1, SAP130, AMMECR1L, POLR2D, WDR33 |
| 2 | 5,057,634 | 5,087,336 | 5 | rs136843388 | 5,077,763 | 0.131 | 0.45 | 1.11 × 10–9 | PROC | Upstream | MYO7B, IWS1, MAP3K2,ERCC3, CYP27C1, BIN21 |
| 2 | 5,349,576 | 5,358,183 | 3 | rs109091526 | 5,358,183 | 0.082 | 0.47 | 3.42 × 10–10 | CYP27C1 | Downstream | LIMS2, GPR17, MYO7B, IWS1, PROC, MAP3K2, ERCC3, BIN1, NAB1, NEMP2, MFSD6 |
| 2 | 5,371,014 | 5,423,184 | 2 | rs109684524 | 5,371,014 | 0.089 | 0.47 | 7.89 × 10–11 | BIN1 | Upstream | LIMS2, GPR17, MYO7B, IWS1, PROC, MAP3K2, ERCC3, CYP27C1, NAB1, NEMP2, MFSD6 |
| 2 | 6,052,068 | 6,052,977 | 2 | rs110937765 | 6,052,977 | 0.097 | 0.39 | 4.44 × 10–12 | HIBCH | Intron | NAB1, NEMP2, MFSD6, INPP1, MSTN, PMS1 |
| 8 | 8,086,908 | 8,092,859 | 3 | rs135213669 | 8,089,690 | 0.013 | 0.39 | 9.45 × 10–8 | MTMR9 | Downstream | FDFT1, NEIL2, GATA4, BLK, FAM167A, TDH, XKR6, PINX1 |
| 11 | 22,056,688 | 22,059,527 | 3 | rs43673407 | 22,059,527 | 0.063 | 0.50 | 3.91 × 10–6 | THUMPD2 | Intron | MAP4K3, TMEM178A, SLC8A1 |
| 13 | 59,936,331 | 59,936,944 | 2 | rs136199851 | 59,936,944 | 0.065 | 0.48 | 9.15 × 10–7 | SIRPD | Downstream | FAM209A, RTF2, GCNT7, CASS4, CSTF1, AURKA, FAM210B, MC3R |
| 14 | 21,713,699 | 25,937,514 | 3 | rs41725494 | 25,934,977 | 0.089 | 0.49 | 1.71 × 10–6 | CA8 | Upstream | RAB2A, CHD7 |
| 18 | 44,742,185 | 44,751,188 | 3 | rs43088759 | 44,749,396 | 0.066 | 0.21 | 1.39 × 10–6 | LSM14A | Intron | LSM14A, GPI, PDCD2L, UBA2, WTIP |